Obamacare enrollments in health insurance exchanges for the 2025 enrollment period have reached 24.2M, an all-time high. Read ...

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration said a record 24.2 million Americans enrolled in individual coverage under the Affordable Care Act ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price controls for the selected drugs will become effective in 2027.

CMS has named 15 additional prescription drugs, including diabetes medication Ozempic, for price negotiations under the Inflation Reduction Act. This marks the second round of negotiations aimed at ...

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has ...

Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare ...

The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration.

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

Xavier Becerra, No. 23-55157 (9th Cir ... 4th 882 (D.C. Cir. 2024). Further, CMS has already capitulated to the Bridgeport Hospital decision and discontinued the low-wage-index policy for fiscal ...

WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- Folks need to act now if they want health insurance coverage starting Jan. 1 through an Affordable Care Act marketplace, officials and experts say.